<DOC>
	<DOCNO>NCT01748097</DOCNO>
	<brief_summary>The investigator use bicarbonate inject intravenous line change exhale end-tidal carbon dioxide verify whether IV line vein surround tissue</brief_summary>
	<brief_title>Intravenous Bicarbonate To Verify The Correct Position IV Catheters Oncological Patients Oncological Patients Receiving Chemotherapy</brief_title>
	<detailed_description>The method prove useful previous phase I , II study . Now investigator move assess method phase III study oncological patient . patient subject intravenous chemotherapy eligible ( see also inclusion/exclusion criterion ) . Once consent obtain patient IV line place . line place categorized clinical team 3 category : 1 . IV place ready use chemotherapy ( good blood return ) 2 . Doubtful position ( blood return/ little blood return bu flush well ) . 3 . IV place . Study design Category 1 . IV bicarbonate 4.2 % 20 cc NS 20 cc randomize fashion Category 2. Category 3 . No injection</detailed_description>
	<criteria>age 1880 oncological disease require intravenous chemotherapy 1. refusal participate 2. lung disease acute chronic sPo2 &lt; 92 % , PaCO2 &gt; 50 3. renal failure Creatinine &gt; 2 mg % 4. metabolic alkalosis HCO3 &gt; 30 meq/L 5. medication affect bicarbonate level : Bicarbonate , Diamox , Fusid 6. obesity BMI &gt; 38 7. congestive heart failure EF &lt; 40 % clinical sign congestive heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>infiltration</keyword>
	<keyword>extravasation</keyword>
	<keyword>sodium bicarbonate</keyword>
	<keyword>capnography</keyword>
	<keyword>end tidal carbon dioxide</keyword>
	<keyword>chemotherapy</keyword>
</DOC>